Bovine viral diarrhea virus type 1b vaccine compositions and methods
AssigneeEli Lilly and Company
InventorsDale Wade Weise, James Robert Harris
Life of this patent
Estimating the term…
Abstract
Disclosed are immunogenic compositions, and methods for their use in the formulation and administration of therapeutic and prophylactic pharmaceutical agents. In particular, the invention provides immunogenic compositions and methods for preventing, treating, managing, and/or ameliorating a viral or microbial infection, or one or more symptoms thereof, including, for example, those infections giving rise to shipping fever, bovine respiratory disease complex, and/or bovine viral diarrhea, particularly in susceptible or infected animals.
Claims25
An immunogenic composition comprising:
- a modified, live bovine viral diarrhea virus type 1b (BVDV-1b), a veterinary-acceptable carrier, and optionally an adjuvant.
(canceled)
9-11. (canceled)
15-17. (canceled)
A method for preventing shipping fever in an animal, comprising administering to the animal a prophylactically-effective amount of a composition comprising a modified, live BVDV-1b virus, a veterinary-acceptable carrier, and optionally an adjuvant.
(canceled)
A method for preventing, treating, managing, or ameliorating one or more symptoms of a disease caused by a pestivirus in an animal susceptible to pestivirus infection, comprising administering to the animal a prophylactically- or therapeutically-effective amount of a composition comprising a modified, live BVDV-1b virus, a pharmaceutically-acceptable carrier, and optionally an adjuvant.
(canceled)
A method for protecting an animal against disease caused by BVDV-1b, comprising administering to the animal a prophylactically-effective amount of a composition comprising a modified, live BVDV-1b virus and a pharmaceutically-acceptable carrier.
27-28. (canceled)
Dependencies are inferred from the claim text.